Home
Mail
TV
News
Sport
Finance
Lifestyle
Entertainment
Weather
Mobile
Yahoo
Mail
Cost Of Living
Watchlists
My Portfolios
Markets
Money
Work
Technology
Industries
Give Feedback
Australia markets open in 3 hours 28 minutes
ALL ORDS
7,932.00
+25.40
(+0.32%)
AUD/USD
0.6475
-0.0095
(-1.44%)
ASX 200
7,664.10
+26.70
(+0.35%)
OIL
81.64
-0.99
(-1.20%)
GOLD
2,303.30
-54.40
(-2.31%)
Bitcoin AUD
92,120.55
-5,179.55
(-5.32%)
Celyad Oncology SA (CLYYF)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.3580
0.0000
(0.00%)
At close: 09:30AM EDT
Summary
Chart
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
44
0
0
5
Cost of revenue
44
0
0
0
Gross profit
0
0
0
5
Operating expenses
Research development
10,540
18,928
20,773
21,522
Selling general and administrative
7,757
10,337
9,665
9,315
Total operating expenses
8,803
20,263
26,909
26,220
Operating income or loss
-8,803
-20,263
-26,909
-26,215
Interest expense
91
197
255
434
Total other income/expenses net
-
-20,422
523
9,228
Income before tax
-30,554
-40,870
-26,502
-17,204
Income tax expense
65
65
10
0
Income from continuing operations
-30,619
-40,935
-26,512
-17,204
Net income
-30,619
-40,935
-26,512
-17,204
Net income available to common shareholders
-30,619
-40,935
-26,512
-17,204
Basic EPS
-1.36
-1.81
-1.70
-1.23
Diluted EPS
-1.36
-1.81
-1.70
-1.23
Basic average shares
22,558
22,594
15,604
13,942
Diluted average shares
22,558
22,594
15,604
13,942
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.